Literature DB >> 24630810

Incidence of pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment.

K Nakano1, L Inagaki1, J Tomomatsu1, N Motoi2, T Gokita1, K Ae1, T Tanizawa1, T Shimoji1, S Matsumoto1, S Takahashi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24630810     DOI： 10.1016/j.clon.2014.02.010

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  8 in total

1.  A Case Report of Secondary Simultaneous Bilateral Pneumothorax Due to Pazopanib Treatment.

Authors:  Burçin Çelik; Zeynep Pelin Sürücü; Volkan Yılmaz; Hale Kefeli Çelik
Journal:  Turk Thorac J       Date:  2018-01-01

2.  Spontaneous Pneumothoraces and Hemothoraces in Sarcomas.

Authors:  Fatima Ezzeddine; Shadia Jalal
Journal:  Cureus       Date:  2017-12-03

3.  Bilateral spontaneous pneumothorax and massive pneumomediastinum under Pazopanib therapy.

Authors:  Giovanni Leuzzi; Gabriele Alessandrini; Virginia Ferraresi; Gianluigi Ferretti; Daniele Forcella; Francesco Facciolo
Journal:  Thorac Cancer       Date:  2015-01-07       Impact factor: 3.500

4.  A randomized, double-blind, placebo-controlled, Phase III study of pazopanib in patients with soft tissue sarcoma: results from the Japanese subgroup.

Authors:  Akira Kawai; Nobuhito Araki; Hiroaki Hiraga; Hideshi Sugiura; Akihiko Matsumine; Toshifumi Ozaki; Takafumi Ueda; Takeshi Ishii; Taito Esaki; Michiko Machida; Nobuaki Fukasawa
Journal:  Jpn J Clin Oncol       Date:  2016-02-10       Impact factor: 3.019

5.  Pneumothorax during Pazopanib Treatment in Patients with Soft-Tissue Sarcoma: Two Case Reports and a Review of the Literature.

Authors:  Yoshiro Nakahara; Tomoya Fukui; Ken Katono; Yuuki Nishizawa; Yusuke Okuma; Masachika Ikegami; Jiichiro Sasaki; Noriyuki Masuda
Journal:  Case Rep Oncol       Date:  2017-04-18

6.  Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysis.

Authors:  Kenji Nakano; Noriko Motoi; Junichi Tomomatsu; Tabu Gokita; Keisuke Ae; Taisuke Tanizawa; Seiichi Matsumoto; Shunji Takahashi
Journal:  BMC Cancer       Date:  2016-09-23       Impact factor: 4.430

7.  Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study.

Authors:  Bruce Sabath; Hasan A Muhammad; Amulya Balagani; David E Ost; Erik Vakil; Tahreem Ahmed; Macarena R Vial; Horiana B Grosu
Journal:  BMC Cancer       Date:  2018-10-01       Impact factor: 4.430

8.  Secondary pneumothorax as a potential marker of apatinib efficacy in osteosarcoma: a multicenter analysis.

Authors:  Zhichao Tian; Huimin Liu; Yao Zhao; Xiaofeng Wang; Hongyan Ren; Fan Zhang; Po Li; Peng Zhang; Jiaqiang Wang; Weitao Yao
Journal:  Anticancer Drugs       Date:  2021-01-01       Impact factor: 2.389
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.